Journal of the American Chemical Society
Communication
the basis of these observations, we assign 420-Ar as a cresol−
diiron adduct resulting from hydroxylation of toluene.
In the final phase, 420-Ar decays with a rate constant of 0.61
correspond to any one of many (hydro)peroxo−diiron
̈
conformations. Because 420A is long-lived and has Mossbauer
properties similar to those observed and calculated for μ-1,2-
−1
11d,16,17
s , and the absorbance at 420 and 675 nm decreases. These
changes are consistent with product release from the active site.
The rate constant associated with this step is much smaller than
that observed in our single-turnover experiments but is similar
peroxodiiron intermediates,
as such a species.
we tentatively assign 420A
Previous O -activation experiments reported half-sites
2
4
reactivity with respect to the hydroxylase dimer. The current
12
to the rate constant for steady-state turnover. Thus, release of
product may be rate-limiting for steady-state turnover, as
previously proposed for the analogous BMM toluene 4-
monooxygenase (T4MO) on the basis of X-ray crystallographic
work shows greater than 50% reactivity. This difference in
activity may be a result of including ToMOC or of the ratio of
O to ToMOH used in our experiments. Here, 1.25 and 6.25
2
equiv of O per diiron site are present in the Mo
̈
ssbauer and
̈
2
1
3
data. O activation in the presence of phenol proved to be
single-turnover studies, respectively. In previous Mossbauer and
2
4
much more complex than that observed with toluene (Figure
S9), probably because of the formation of both diiron−phenol
and diiron−catechol adducts.
single-turnover studies, we estimate that the ratios were 0.6
2
Three important conclusions are evident from this work: (i)
ToMOC is critical for the formation of an active hydroxylating
species; (ii) the previously undetected species, 420A, decays
rapidly upon addition of toluene, consistent with arene
oxidation; (iii) ToMOH is capable of greater than half-sites
reactivity.
In summary, we have demonstrated the importance of the
natural reduction system for efficient hydroxylation and O2
activation by the multicomponent diiron protein ToMO. Using
this knowledge, we were able to identify a previously
unobserved species, 420A, during O activation by the diiron
2
protein ToMO. A proposed scheme that accounts for the
The difference in reactivity between the natural system and
the 2e-MV simulation is surprising given that the BMM soluble
observed O -activation kinetics is given in Figure 4B. Further
2
insight into the effects of ToMOC at a molecular level would
benefit from high-resolution structural data of the oxidized and
reduced complexes between ToMOC and ToMOH.
14
turnover using 2e-MV as the reduction system (Figure S10).
The non-heme diiron protein stearoyl-acyl carrier protein
desaturase (Δ9D) also forms an inactive peroxo species when
the diiron reducing protein is replaced with sodium
ASSOCIATED CONTENT
Supporting Information
■
*
S
1
5
dithionite. For both ToMO and Δ9D, the reductases clearly
promote activity, but it is also possible that dithionite inhibits
activity, resulting in low turnover when dithionite present in
2
a,15
Experimental details, evaluation of 420B, Figures S1−
S10, and Tables S1−S3 (PDF)
excess.
A recent X-ray structure of the hydroxylase and Rieske
protein complex for T4MO hints at a possible mechanism for
Rieske protein function. In the 2.05 Å structure of the complex,
residue E104 adopts a different conformation than those
AUTHOR INFORMATION
16
previously reported for BMMs (Figure 4A). The new position
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
This work was supported by NIH Grant GM032134 from the
National Institute of General Medical Sciences (NIGMS).
A.D.L. was supported in part by the NIH NIGMS
Biotechnology Training Program Grant T32 GM008334. The
authors acknowledge Tsai-Te Lu and Woon Ju Song for helpful
discussions.
Figure 4. Influences of ToMOC on the activity of ToMO . On the
red
basis of the Rieske−hydroxylase complex of T4MO, we propose that
the unusual E104 conformation (A) may be responsible for the activity
seen in the presence of ToMOC. A mechanistic scheme consistent
with the activity of ToMOred is provided in (B).
REFERENCES
■
(
1) Kurtz, D. M.; Boice, E.; Caranto, J. D.; Frederick, R. E.; Masitas,
C. A.; Miner, K. D. In Encyclopedia of Inorganic and Bioinorganic
Chemistry; John Wiley & Sons: Chichester, U.K., 2011.
(
2) (a) Cafaro, V.; Scognamiglio, R.; Viggiani, A.; Izzo, V.; Passaro, I.;
16
of E104 alters the hydrogen bonding at the active site.
Notomista, E.; Dal Piaz, F.; Amoresano, A.; Casbarra, A.; Pucci, P.; Di
Donato, A. Eur. J. Biochem. 2002, 269, 5689. (b) Leahy, J. G.;
Batchelor, P. J.; Morcomb, S. M. Fems Microbiol Rev. 2003, 27, 449.
Computational analyses of peroxo intermediates formed at
carboxylate-bridged diiron centers indicate that the transition
near 420 nm corresponds to ligand-to-metal charge transfer
from both the carboxylate and the peroxo ligands bound to the
diiron site and that these transitions are sensitive to the
carboxylate orientation. Thus, the differing absorption
features between the 2e-MV-reduced system and the ToMOred
system may arise from conformational changes in E104. As to
the structure, the newly discovered intermediate 420A may
(
3) Cafaro, V.; Notomista, E.; Capasso, P.; Di Donato, A. Appl.
Environ. Microb 2005, 71, 4736.
4) Murray, L. J.; Naik, S. G.; Ortillo, D. O.; Garcıa
K.; Huynh, B. H.; Lippard, S. J. J. Am. Chem. Soc. 2007, 129, 14500.
5) Tinberg, C. E.; Song, W. J.; Izzo, V.; Lippard, S. J. Biochemistry
2011, 50, 1788.
(6) Makris, T. M.; Chakrabarti, M.; Mu
Natl. Acad. Sci. U. S. A. 2010, 107, 15391.
(
́
-Serres, R.; Lee, J.
1
7
(
̈
nck, E.; Lipscomb, J. D. Proc.
C
J. Am. Chem. Soc. XXXX, XXX, XXX−XXX